Fresh Rounds

Altay Therapeutics, Inc. funding

Altay Therapeutics, Inc., a biotechnology company based in San Carlos, CA, filed a Form D with the SEC on October 2, 2026 and reported $15.7M raised of a $45.1M offering.

Amount raised$15.7M
Offering size$45.1M
Filed with the SECOctober 2, 2026
First saleSeptember 17, 2026
IndustryBiotechnology
SecuritiesEquity
LocationSan Carlos, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far19
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in California